Markets
Quanterix Stock Plunges 9% After Its CEO Resigns For Another Healthcare Opportunity
The company kept its 2026 outlook and put its commercial chief in interim charge while the board searches for a permanent CEO.
Quanterix (QTRX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Markets
The company kept its 2026 outlook and put its commercial chief in interim charge while the board searches for a permanent CEO.
SEC Filings
Commercial chief Jim Gute took over as interim CEO while the board searches for a permanent leader.
Markets
Revenue rose 6.3% from the second quarter, while management expects to end the year debt-free with about $70 million in cash.
Earnings
Diagnostic-partner revenue fell to $1.2 million as recurring testing sales failed to offset fewer instrument placements.
Earnings
Lower expenses narrowed the net loss, while Quanterix tightened its annual sales outlook and expanded Alzheimer’s testing partnerships.